Free Trial

PetVivo (PETV) Competitors

PetVivo logo
$0.45 +0.00 (+0.45%)
(As of 12/20/2024 04:04 PM ET)

PETV vs. XAIR, STIM, POCI, IRIX, BSGM, FEMY, CODX, DRIO, VVOS, and ALUR

Should you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include Beyond Air (XAIR), Neuronetics (STIM), Precision Optics (POCI), IRIDEX (IRIX), BioSig Technologies (BSGM), Femasys (FEMY), Co-Diagnostics (CODX), DarioHealth (DRIO), Vivos Therapeutics (VVOS), and Allurion Technologies (ALUR). These companies are all part of the "medical equipment" industry.

PetVivo vs.

Beyond Air (NASDAQ:XAIR) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability, community ranking and analyst recommendations.

PetVivo has a net margin of -889.99% compared to Beyond Air's net margin of -2,369.17%. Beyond Air's return on equity of -227.29% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
Beyond Air-2,369.17% -227.29% -106.51%
PetVivo -889.99%-1,213.96%-266.53%

In the previous week, Beyond Air's average media sentiment score of 0.00 equaled PetVivo'saverage media sentiment score.

Company Overall Sentiment
Beyond Air Neutral
PetVivo Neutral

PetVivo has lower revenue, but higher earnings than Beyond Air. PetVivo is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beyond Air$2.34M12.42-$60.24M-$1.41-0.29
PetVivo$1.05M8.85-$10.95M-$0.48-0.94

Beyond Air received 48 more outperform votes than PetVivo when rated by MarketBeat users.

CompanyUnderperformOutperform
Beyond AirOutperform Votes
48
69.57%
Underperform Votes
21
30.43%
PetVivoN/AN/A

Beyond Air presently has a consensus target price of $3.67, suggesting a potential upside of 809.62%. Given Beyond Air's stronger consensus rating and higher probable upside, equities analysts clearly believe Beyond Air is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beyond Air
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Beyond Air has a beta of -0.23, suggesting that its stock price is 123% less volatile than the S&P 500. Comparatively, PetVivo has a beta of 2.42, suggesting that its stock price is 142% more volatile than the S&P 500.

31.5% of Beyond Air shares are held by institutional investors. Comparatively, 24.5% of PetVivo shares are held by institutional investors. 20.1% of Beyond Air shares are held by insiders. Comparatively, 20.1% of PetVivo shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Beyond Air beats PetVivo on 11 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PETV vs. The Competition

MetricPetVivoSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$9.26M$4.34B$5.13B$9.07B
Dividend YieldN/A44.57%5.08%4.23%
P/E Ratio-0.9425.3789.5817.17
Price / Sales8.8545.951,116.12116.95
Price / CashN/A43.4542.8237.86
Price / Book6.437.094.774.78
Net Income-$10.95M$13.64M$120.15M$225.60M
7 Day Performance9.76%-2.93%-1.92%-1.23%
1 Month Performance-4.46%0.28%11.47%3.36%
1 Year Performance-61.21%40.76%30.54%16.60%

PetVivo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PETV
PetVivo
N/A$0.45
+0.4%
N/A-47.0%$9.26M$1.05M-0.9420News Coverage
High Trading Volume
XAIR
Beyond Air
4.1445 of 5 stars
$0.46
-1.0%
$3.67
+696.8%
-78.9%$33.22M$1.16M-0.3370
STIM
Neuronetics
2.9294 of 5 stars
$1.09
-2.7%
$4.67
+328.1%
-47.5%$33.08M$71.35M-0.89180News Coverage
POCI
Precision Optics
N/A$5.15
+1.0%
N/A-16.2%$32.70M$19.10M0.0080High Trading Volume
IRIX
IRIDEX
0.3474 of 5 stars
$1.69
-1.7%
$2.00
+18.3%
-37.2%$28.12M$48.43M-2.57120Analyst Forecast
News Coverage
BSGM
BioSig Technologies
1.2184 of 5 stars
$1.60
+8.8%
$2.75
+71.9%
-69.0%$27.58M$39,000.000.0050
FEMY
Femasys
2.1386 of 5 stars
$1.15
-3.4%
$10.00
+769.6%
+23.4%$26.33M$1.26M-1.4730
CODX
Co-Diagnostics
3.8281 of 5 stars
$0.79
-5.0%
$1.50
+89.8%
-38.1%$25.23M$7.32M-0.60100
DRIO
DarioHealth
2.2551 of 5 stars
$0.70
-3.8%
$4.00
+468.2%
-50.9%$24.00M$23.05M-0.75200News Coverage
Positive News
VVOS
Vivos Therapeutics
2.8401 of 5 stars
$4.95
+7.4%
$6.30
+27.3%
-59.0%$23.96M$13.80M-0.81160Positive News
ALUR
Allurion Technologies
2.0377 of 5 stars
$0.34
-2.8%
$2.88
+755.7%
-89.7%$21.63M$34.75M-0.70501Gap Up

Related Companies and Tools


This page (NASDAQ:PETV) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners